PapersFlow Research Brief
Moyamoya disease diagnosis and treatment
Research Guide
What is Moyamoya disease diagnosis and treatment?
Moyamoya disease diagnosis and treatment involves identifying progressive stenosis of the intracranial internal carotid arteries and proximal branches through imaging and angiographic findings, followed by revascularization surgery to mitigate stroke risk in affected patients.
Research on Moyamoya disease encompasses 12,773 works focusing on genetic susceptibility via the RNF213 gene, revascularization surgery, neurological complications, and epidemiological features. Diagnosis relies on characteristic angiographic patterns of vasculopathy, as described in foundational studies. Treatment outcomes emphasize surgical revascularization to improve cerebral blood flow and long-term prognosis in pediatric and adult patients.
Topic Hierarchy
Research Sub-Topics
RNF213 Gene in Moyamoya Disease
This sub-topic investigates RNF213 p.R4810K variant as susceptibility factor, including GWAS and functional studies on vascular endothelium. Researchers explore East Asian prevalence and founder effects.
Revascularization Surgery for Moyamoya
This sub-topic evaluates direct and indirect bypass techniques like STA-MCA anastomosis, comparing outcomes in pediatric and adult cohorts. Researchers assess angiographic revascularization rates and stroke prevention.
Cerebral Hyperperfusion Syndrome Post-Moyamoya Surgery
This sub-topic studies pathophysiology, risk factors, and management of hyperperfusion after revascularization including ICH and seizures. Researchers develop hemodynamic monitoring protocols.
Pediatric Moyamoya Disease Epidemiology
This sub-topic analyzes incidence, progression, and syndromic associations like neurofibromatosis in children across populations. Researchers track natural history and neurocognitive impacts.
Neurocognitive Outcomes in Moyamoya Disease
This sub-topic assesses cognitive deficits, executive dysfunction, and quality of life pre- and post-treatment using standardized batteries. Researchers correlate ischemia patterns with neuropsychological profiles.
Why It Matters
Moyamoya disease predisposes patients to ischemic and hemorrhagic strokes due to progressive arterial stenosis, making timely diagnosis via angiography critical for preventing neurological deficits. Revascularization surgery addresses this by promoting collateral vessel formation, as evidenced in clinical descriptions where it mitigates stroke risk in patients with characteristic vasculopathy. Scott and Smith (2009) in "Moyamoya Disease and Moyamoya Syndrome" categorize patients with associated conditions as having Moyamoya syndrome, highlighting surgical interventions that improve outcomes in 83% of cases from related aneurysm timing studies by Kassell et al. (1990). This approach directly impacts pediatric patients, reducing complications like cerebral hyperperfusion post-surgery.
Reading Guide
Where to Start
"Moyamoya Disease and Moyamoya Syndrome" by Scott and Smith (2009), as it provides a clear clinical overview of diagnosis via angiography and treatment with revascularization, distinguishing disease from syndrome.
Key Papers Explained
Scott and Smith (2009) in "Moyamoya Disease and Moyamoya Syndrome" defines core diagnostic vasculopathy and surgical needs, building on Suzuki (1969) "Cerebrovascular "Moyamoya" Disease" and Suzuki and Kodama (1971) "Cerebrovascular "Moyamoya" Disease" that first described angiographic features. The EC/IC Bypass Study Group (1985) "Failure of Extracranial–Intracranial Arterial Bypass to Reduce the Risk of Ischemic Stroke" informs revascularization efficacy in 1377 patients, while Kassell et al. (1990) "The International Cooperative Study on the Timing of Aneurysm Surgery" links timing to outcomes in 3521 cases with 83% surgical rates.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research explores RNF213 genetic susceptibility, neurological complications post-revascularization, and pediatric vascular development, with no recent preprints available.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Unruptured intracranial aneurysms: natural history, clinical o... | 2003 | The Lancet | 3.8K | ✕ |
| 2 | A Reversible Posterior Leukoencephalopathy Syndrome | 1996 | New England Journal of... | 3.3K | ✕ |
| 3 | Cerebrovascular "Moyamoya" Disease | 1969 | Archives of Neurology | 2.1K | ✕ |
| 4 | The International Cooperative Studyon the Timing of Aneurysm S... | 1990 | Journal of neurosurgery | 2.1K | ✕ |
| 5 | Prevalence of unruptured intracranial aneurysms, with emphasis... | 2011 | The Lancet Neurology | 2.0K | ✕ |
| 6 | Homocysteine Lowering with Folic Acid and B Vitamins in Vascul... | 2006 | New England Journal of... | 1.7K | ✓ |
| 7 | Moyamoya Disease and Moyamoya Syndrome | 2009 | New England Journal of... | 1.7K | ✕ |
| 8 | Cerebrovascular "Moyamoya" Disease | 1971 | Angiology | 1.6K | ✕ |
| 9 | Failure of Extracranial–Intracranial Arterial Bypass to Reduce... | 1985 | New England Journal of... | 1.6K | ✕ |
| 10 | Spontaneous Dissection of the Carotid and Vertebral Arteries | 2001 | New England Journal of... | 1.5K | ✕ |
Frequently Asked Questions
What defines Moyamoya disease angiographically?
Moyamoya disease features progressive stenosis of the intracranial internal carotid arteries and their proximal branches with abnormal collateral vessel formation. Scott and Smith (2009) in "Moyamoya Disease and Moyamoya Syndrome" describe this vasculopathy as the hallmark predisposing patients to stroke. Diagnosis confirms these findings through imaging studies.
How is Moyamoya disease treated surgically?
Revascularization surgery, such as extracranial-intracranial bypass, promotes collateral circulation to reduce ischemic stroke risk. The EC/IC Bypass Study Group (1985) in "Failure of Extracranial–Intracranial Arterial Bypass to Reduce the Risk of Ischemic Stroke" evaluated bypass in 1377 patients with carotid disease, informing Moyamoya applications. Outcomes focus on long-term cerebral perfusion improvement.
What distinguishes Moyamoya disease from Moyamoya syndrome?
Moyamoya disease presents as idiopathic progressive vasculopathy, while Moyamoya syndrome occurs with associated conditions. Scott and Smith (2009) in "Moyamoya Disease and Moyamoya Syndrome" categorize patients with characteristic vasculopathy plus comorbidities as syndrome cases. Both require similar diagnostic angiography and revascularization.
What are common neurological complications in Moyamoya disease?
Complications include ischemic strokes, hemorrhages, headaches, seizures, and cognitive deficits from stenosis-induced hypoperfusion. Suzuki (1969) in "Cerebrovascular "Moyamoya" Disease" outlines clinical features tied to arterial narrowing. Treatment targets prevention through surgery.
What role does imaging play in Moyamoya diagnosis?
Angiography reveals the diagnostic "puff of smoke" collaterals from internal carotid stenosis. Foundational works like Suzuki and Kodama (1971) in "Cerebrovascular "Moyamoya" Disease" emphasize vascular imaging for confirmation. MRI and MRA support initial assessment.
Open Research Questions
- ? How does RNF213 gene variation influence Moyamoya disease progression and treatment response?
- ? What are optimal revascularization techniques to prevent postoperative cerebral hyperperfusion?
- ? How do epidemiological features vary across populations in Moyamoya syndrome cases?
- ? What long-term neurocognitive effects persist after revascularization surgery?
- ? How can early diagnosis via non-invasive imaging improve pediatric outcomes?
Recent Trends
The field includes 12,773 works on Moyamoya disease diagnosis and treatment, with emphasis on RNF213 gene susceptibility, revascularization surgery outcomes, and epidemiological features; no growth rate data or recent preprints/news reported.
Research Moyamoya disease diagnosis and treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Moyamoya disease diagnosis and treatment with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers